Q2 Earnings Estimate for CHRN Issued By Northland Securities

ChronoScale Corporation Common Stock (NASDAQ:CHRN) – Analysts at Northland Securities issued their Q2 2026 EPS estimates for shares of ChronoScale Corporation Common Stock in a research report issued on Friday, September 18th. Northland Securities analyst N. Chokshi forecasts that the company will earn ($0.08) per share for the quarter. Northland Securities has a “Outperform” rating and a $32.00 price target on the stock. The consensus estimate for ChronoScale Corporation Common Stock’s current full-year earnings is ($0.10) per share.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The firm had revenue of $18.40 million during the quarter.

Separately, Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $19.00.

ChronoScale Corporation Common Stock Price Performance

Shares of NASDAQ:CHRN opened at $21.69 on Tuesday. The company’s fifty day moving average price is $21.52 and its 200-day moving average price is $17.19. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.51 and a quick ratio of 0.51. The firm has a market capitalization of $3.16 billion, a price-to-earnings ratio of -4.03 and a beta of 0.98. ChronoScale Corporation Common Stock has a one year low of $3.50 and a one year high of $30.00.

Hedge Funds Weigh In On ChronoScale Corporation Common Stock

A hedge fund recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc grew its holdings in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the period. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 as of its most recent SEC filing. 6.42% of the stock is owned by institutional investors and hedge funds.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.